John Watts plans Rule 144 sale of CW shares

John Watts filed a Rule 144 notice to sell 652 common shares of CW.

Accepted by SEC EDGAR 02/04/2026 - 05:09 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

John Watts filed a Rule 144 notice to sell 652 common shares of CW. The planned sale, through UBS Financial Services Inc. on the NYSE, has an aggregate market value of $407,748.55, with 36,874,638 shares of this class outstanding.

The 652 shares were acquired on 02/03/2026 via a performance stock vest from the issuer. Over the prior three months, John Watts sold additional CW common shares in several transactions totaling 688 shares, with reported gross proceeds ranging from $61,935 to $172,800 per transaction.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does CW's Form 144 filing by John Watts disclose?

The Form 144 discloses that John Watts plans to sell 652 CW common shares on the NYSE. The filing lists an aggregate market value of $407,748.55 and confirms the shares were recently acquired through a performance stock vest from the issuer.

How many CW shares is John Watts planning to sell under Rule 144?

John Watts plans to sell 652 CW common shares under Rule 144. The filing notes these shares have an aggregate market value of $407,748.55 and will be sold through UBS Financial Services Inc. on the NYSE, with an approximate sale date of February 4, 2026.

How did John Watts acquire the 652 CW shares listed in the Form 144?

The 652 CW common shares were acquired on February 3, 2026, through a performance stock vest transaction from the issuer. The filing shows the same date as the payment date, marked as “n/a” for nature of payment, indicating no separate cash consideration was detailed.

What prior CW stock sales by John Watts are reported in the last three months?

The filing reports four prior CW common stock sales by John Watts in the last three months: 175 shares on November 25, 2025, 118 shares on December 23, 2025, 107 shares on January 5, 2026, and 288 shares on January 8, 2026, with stated gross proceeds for each.

On which exchange and through which broker will the CW shares be sold?

The planned sale of 652 CW common shares will be executed on the NYSE. The broker listed is UBS Financial Services Inc., located at 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ 07086, as disclosed in the securities information section of the filing.

How many CW shares of this class are outstanding according to the filing?

The filing states that 36,874,638 shares of this class of CW common stock are outstanding. This figure provides context for the planned 652-share sale disclosed by John Watts but is not itself part of the shares being sold under this specific Form 144 notice.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001926867
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Curtiss-Wright Corporation
SEC File Number	001-00134
Address of Issuer	130 Harbour Place Drive, Suite 300 Davidson NORTH CAROLINA 28036
Phone	973-541-3753
Name of Person for Whose Account the Securities are To Be Sold	John Watts
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	UBS Financial Services Inc 1000 Harbor Blvd 3rd Floor Weehawken NJ 07086	652	407748.55	36874638	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	02/03/2026	performance stock vest	issuer			652	02/03/2026	n/a

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
John Watts 130 Harbour Place Drive, Suite 300 Davidson NC 28036	common	11/25/2025	175	95719
John Watts 130 Harbour Place Drive, Suite 300 Davidson NC 28036	common	12/23/2025	118	67850
John Watts 130 Harbour Place Drive, Suite 300 Davidson NC 28036	common	01/05/2026	107	61935
John Watts 130 Harbour Place Drive, Suite 300 Davidson NC 28036	common	01/08/2026	288	172800

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/Mijo Suric, for UBS Financial Services Inc, as attorney-in-fact for John Watts
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)